Jonathan Lambert
[Copyright 2024 NPR]
-
A new study looks at lives saved by USAID in the past and what the future without the agency will look like. -
A newly approved HIV medication provides near-total protection against infection with just two injections a year. It's called Lenacapavir. But the high price of the drug could limit its reach.
-
A drug called lenacapavir, administered in two injections a year, offers protection from HIV comparable to daily pills. One looming question: Will it be affordable for lower resource countries? -
Global health specialists talk about the consequences of the full or partial ban on travel to the U.S. from 19 countries. -
For nearly 15 years, Dennis Burton worked on creating an HIV vaccine considered to be one of the leading vaccine efforts. In late May, he learned the Trump administration was ending the project.
-
On May 30, a team of researchers funded by the National Institutes of Health got the word: Funding for their vaccine development program will end next year. -
These colorful snakes aren't just works of art. Erected for the World Health Assembly, they're meant to draw attention to an extremely neglected health issue: snakebite. -
Mariam Mohammed says her younger son died when she could not get treatment for him at a U.S.-funded clinic that had temporarily closed. Researchers say there are many thousands of cases like his. -
NPR interviews Maria Van Kherkove, the infectious disease epidemiologist who is a leader in the World Health Organization. -
At the World Health Assembly, 193 member nations voted to adopt a treat calling for better preventive measures and global cooperation. But there are still details to hash out.
